Markets.com Logo
euEnglish
LoginSign Up

Stocks surge as Russia claims to have a Covid-19 vaccine

Aug 11, 2020
2 min read
Table of Contents
  • 1. Putin announces registration of world’s first coronavirus vaccine
  • 2. Doubts over Russian vaccine claims

Stocks have leapt higher today after Russia claimed that it had registered the world’s first vaccine for the new coronavirus.

The Dow has climbed over 350 points higher and the S&P 500 has risen to within touching distance of the all-time high set in February. European stocks have held on to this morning’s gains.

Conversely, safe-haven precious metals are getting hammered, with gold now down over -4% at $1,940.00 and silver crashing -7% to $27.00.

Putin announces registration of world’s first coronavirus vaccine

President Putin claims that the virus works ‘quite effectively, it forms a stable immunity and, I repeat, has passed all the necessary checks’. He also said that one of his daughters has been given the vaccine.

The vaccine has undergone clinical trials, which have been completed in under two months. Phase three trials are expected to start on Wednesday and will involve countries including the United Arab Emirates, the Philippines, and Saudi Arabia.

The vaccine will be called ‘Sputnik V’ in overseas markets. The Russian Direct Investment Firm, Russia’s sovereign wealth fund, is backing the production of the vaccine and claims that over 20 countries have filed preliminary applications for a total of over 1 billion doses so far.

Doubts over Russian vaccine claims

While Putin has hailed the Russian breakthrough and stocks have moved sharply higher, the news has been met with scepticism elsewhere.

A spokesman for the World Health Organisation cautiously said that the body was in contact with Russia about the “possible pre-qualification process for a Covid-19 candidate vaccine which requires rigorous review”.

And former US Food and Drug Administration commissioner and Pfizer board member Dr Scott Gottlieb told CNBC today that, compared to the US efforts, Russia’s vaccine development is ‘certainly not ahead’.

‘They’ve cleared the equivalent, really, of a Phase 1 clinical trial in terms of putting it in 100 to maybe as many as 300 patients so it needs to be evaluated in a large-scale clinical trial,’ Gottlieb said.

Regardless of any cautious noises, markets are powering higher, with investors perhaps repricing their expectations for how far out a working vaccine is.


Risk Warning: this article represents only the author’s views and is for reference only. It does not constitute investment advice or financial guidance, nor does it represent the stance of the Markets.com platform.When considering shares, indices, forex (foreign exchange) and commodities for trading and price predictions, remember that trading CFDs involves a significant degree of risk and could result in capital loss.Past performance is not indicative of any future results. This information is provided for informative purposes only and should not be construed to be investment advice. Trading cryptocurrency CFDs and spread bets is restricted for all UK retail clients. 

Written by
SHARE

Markets

  • Palladium - Cash

    chartpng

    --

    -0.79%
  • EUR/USD

    chartpng

    --

    -0.07%
  • Cotton

    chartpng

    --

    -0.26%
  • AUD/USD

    chartpng

    --

    0.02%
  • Santander

    chartpng

    --

    -1.66%
  • Apple.svg

    Apple

    chartpng

    --

    -1.05%
  • easyJet

    chartpng

    --

    -2.53%
  • VIXX

    chartpng

    --

    0.29%
  • Silver

    chartpng

    --

    -0.41%
Table of Contents
  • 1. Putin announces registration of world’s first coronavirus vaccine
  • 2. Doubts over Russian vaccine claims

Related Articles

KLAR Stock News: Klarna Plans to Raise up to $1.27 Billion in U.S. IPO

KLAR Stock News: Klarna, the Swedish fintech company widely recognized for its buy now, pay later (BNPL) services, has announced its intention to raise up to $1.27 billion through an IPO in the United States.

about 12 hours ago

Asia stock market: Hang Seng Index jumps, Alibaba (BABA) stock surges

Asia stock market: The Asian stock market has recently witnessed notable movements, particularly with the Hang Seng Index experiencing a significant jump and BABA stock seeing a remarkable surge in its stock price.

2 days ago
Markets appear fragile before US nonfarm payrolls report on Friday

Week Ahead: Markets Eye U.S. Non-Farm Payrolls Report

Key economic releases are due in the first week of September 2025. On Monday, 1 September at 01:45 GMT, the Caixin Manufacturing PMI for August is expected at 50, up from 49.5 in July.

3 days ago
Markets.com Logo
google playapp storeweb tradertradingView

Contact Us

support@markets.com +27 104470539

Markets

  • Forex
  • Shares
  • Commodities
  • Indices
  • Crypto
  • ETFs
  • Bonds

Trading

  • Trading Tools
  • Platform
  • Web Platform
  • App
  • TradingView
  • MT4
  • MT5
  • CFD Trading
  • CFD Asset List
  • Trading Info
  • Trading Conditions
  • Trading Hours
  • Trading Calculators
  • Economic Calendar

Learn

  • News
  • Trading Basics
  • Glossary
  • Webinars
  • Traders' Clinic
  • Education Centre

About

  • Why markets.com
  • Global Offering
  • Our Group
  • Careers
  • FAQs
  • Legal Pack
  • Safety Online
  • Complaints
  • Contact Support
  • Help Centre
  • Sitemap
  • Cookie Disclosure
  • Awards and Media

Promo

  • Crypto Trading
  • marketsClub
  • Welcome Bonus
  • Loyal Bonus
  • Referral Bonus

Partnership

  • Affiliation
  • IB

Follow us on

  • Facebook
  • Twitter X
  • Instagram
  • Linkedin
  • Youtube
  • Threads
  • TikTok

Listed on

  • 2023 Best Trading Platform Middle East - International Business Magazine
  • 2023 Best Trading Conditions Broker - Forexing.com
  • 2023 Most Trusted Forex Broker - Forexing.com
  • 2023 Most Transparent Broker - AllForexBonus.com
  • 2024 Best Broker for Beginners, United Kingdom - Global Brands Magazine
  • 2024 Best MT4 & MT5 Trading Platform Europe  - Brands Review Magazine
  • 2024 Top Research and Education Resources Asia - Global Business and Finance Magazine
  • 2024 Leading CFD Broker Africa - Brands Review Magazine
  • 2024 Best Broker For Beginners LATAM - Global Business and Finance Magazine
  • 2024 Best Mobile Trading App MENA - Brands Review Magazine
  • 2024 Best Outstanding Value Brokerage MENA - Global Business and Finance Magazine
  • 2024 Best Broker for Customer Service MENA - Global Business and Finance Magazine
LegalLegal PackCookie DisclosureSafety Online

Payment
Methods

mastercardvisaskrillwire transferAOPAYcapiteceftPayRetailersBeeterller
The www.markets.com/za/ site is operated by Markets South Africa (Pty) Ltd which is a regulated by the FSCA under license no. 46860 and licensed to operate as an Over The Counter Derivatives Provider (ODP) in terms of the Financial Markets Act no.19 of 2012. Markets South Africa (Pty) Ltd is located at BOUNDARY PLACE 18 RIVONIA ROAD, ILLOVO SANDTON, JOHANNESBURG, GAUTENG, 2196, South Africa. 

High Risk Investment Warning: Trading Foreign Exchange (Forex) and Contracts For Difference (CFDs) is highly speculative, carries a high level of risk and is not appropriate for every investor. You may sustain a loss of some or all of your invested capital, therefore, you should not speculate with capital that you cannot afford to lose. You should be aware of all the risks associated with trading on margin. Please read the full  Risk Disclosure Statement which gives you a more detailed explanation of the risks involved.

For privacy and data protection related complaints please contact us at privacy@markets.com. Please read our PRIVACY POLICY STATEMENT for more information on handling of personal data.

Markets.com operates through the following subsidiaries:

Safecap Investments Limited, which is regulated by the Cyprus Securities and Exchange Commission (“CySEC”) under license no. 092/08. Safecap is incorporated in the Republic of Cyprus under company number ΗΕ186196.

Markets International Limited is registered  in the Saint Vincent and The Grenadines (“SVG”) under the revised Laws of Saint Vincent and The Grenadines 2009, with registration number  27030 BC 2023.

Close
Close

set cookie

set cookie

We use cookies to do things like offer live chat support and show you content we think you’ll be interested in. If you’re happy with the use of cookies by markets.com, click accept.